The effect of vitamin D derivatives on vascular calcification associated with inflammation

Nephrology Dialysis Transplantation

Volumn 27, Issue 6, 2012, Pages 2206-2212

  Guerrero, Fatima ^a   Montes De Oca, Addy ^a   Aguilera Tejero, Escolástico ^a   Zafra, Rafael ^a   Rodríguez, Mariano ^b   López, Ignacio ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Inflammation; LPS; TNF ; Vascular calcification; Vitamin D

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALCITRIOL; CALCIUM ION; CREATININE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PARATHYROID HORMONE; PARICALCITOL; PHOSPHATE; PHOSPHORUS; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AORTA; ARTICLE; BLOOD VESSEL CALCIFICATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; NONHUMAN; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; UREMIA;

ANIMALS; AORTA; BLOOD PRESSURE; BLOTTING, WESTERN; BONE DENSITY CONSERVATION AGENTS; CALCINOSIS; CALCITRIOL; CALCIUM; CELLS, CULTURED; CYTOKINES; ERGOCALCIFEROLS; FEMALE; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MUSCLE, SMOOTH, VASCULAR; NEPHRECTOMY; PHOSPHORUS; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UREMIA; VASCULAR DISEASES;

EID: 84861916953     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr555     Document Type: Article

References (34)

1. Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218
2. Goodman WG, London G, Amann K et al. Vascular calcification in chronic kidney disease. Am J Kidney Dis 2004; 43: 572-579
3. Tsirpanlis G. Is inflammation the link between atherosclerosis and vascular calcification in chronic kidney disease? Blood Purif 2007; 25: 179-182
4. Al-Aly Z. Medial vascular calcification in diabetes mellitus and chronic kidney disease: the role of inflammation. Cardiovasc Haematol Disord Drug Targets 2007; 7: 1-6
5. Boström K. Proinflammatory vascular calcification. Circ Res 2005; 96: 1219-1220
6. Nadra I, Mason JC, Philippidis P et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways. A vicious cycle of inflammation and arterial calcification? Circ Res 2005; 96: 1248-1256
7. Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: sources, consequences and therapy. Semin Dial 2002; 15: 329-337
8. Yu Z, Seya K, Daitoku K et al. Tumor necrosis factor-a accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-DLx5 pathway. J Pharmacol Exp Ther 2011; 337: 16-23
9. Teng M, Wolf M, Lowrie E et al. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol theraphy. N Engl J Med 2003; 349: 446-456
10. Teng M, Wolf M, Ofsthun MN et al. Activated Injectable vitamin D and hemodialysis survival: a Historical Cohort study. JAmSoc Nephrol 2005; 16: 1115-1125
11. Cardús A, Panizo S, Parisi E et al. Differential effects of vitamin D analogs on vascular calcification. J Bone Miner Res 2007; 22: 860-866
12. Lopez I, Mendoza FJ, Aguilera-Tejero E et al. The effect of calcitriol, paricalcitol and a calcimimetic on extraosseus calcifications in uremic rats. Kidney Int 2008; 73: 300-307
13. Slatopolsky E, Cozzolino M, Finch JL. Differential effects of 19-nor-(OH)2D2 and 1alpha hydroxyvitamin D2 on calcium and phosphorus in normal and uremic rats. Kidney Int 2002; 62: 1277-1284
14. Seibret E, Levin NW, Kuhlmann MK. Immunomodulating effects of vitamin D analogs in hemodialysis patients. Hemodialysis Int 2005; 9: 25-29
15. Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Bio 2005; 97: 93-101
16. Yee YK, Chintalacharuvu SR, Lu J et al. Vitamin D receptor modulators for inflammation and cancer. Mini Rev Med Chem 2005; 5: 761-778
17. Lomashvili KA, Cobbs S, Hennigar RA et al. Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol 2004; 15: 1392-1401
18. Moncek F, Aguilera G, Jezova D. Insufficient activation of adrenocortical but not adrenomedullary hormones during stress in rats subjected to repeated immune challenge. J Neuroimmunol 2003; 142: 86-92
19. Price PA, Faus SA, Williamson MK. Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Tromb Vasc Biol 2000; 20: 317-327
20. Chomczynski P, Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocynate-phenol-cloroform extraction: twenty something years on. Nat Protoc 2006; 1: 581-585
21. Cohen ML, Douvdevani A, Chaimovitz C et al. Regulation of TNF-a by 1a,25-dihydroxyvitamin D3 in human macrophages from CAPD patients. Kidney Int 2001; 59: 69-75
22. Al-Aly Z. Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy. Transl Res 2008; 151: 233-239
23. Tintut Y, Patel J, Parhami F et al. Tumor necrosis factor-a promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 2000; 102: 2636-2642
24. Villa-Belllosta R, Levi M, Sorribas V. Vascular smooth muscle cell calcification and SLC20 inorganic phosphate transporters: effects of PDGF, TNF-alpha, and Pi. Pflugers Arch 2009; 458: 1151-1161
25. Li JJ, Zhu CG, Yu B et al. The role of inflammation in coronary artery calcification. Ageing Res Rev 2007; 6: 263-270
26. Al-Aly Z, Shao JS, Lai CF et al. Aortic MSX2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/-mice. Arterioscler Thromb Vasc Biol 2007; 27: 2589-2596
27. Ding J, Ghali O, Lencel P et al. TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. Life Sci 2009; 84: 499-504
28. Gilbert L, He X, Farmer P et al. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem 2002; 277: 2695-2701
29. Bradley JR. TNF-mediated inflammatory disease. J Pathol 2008; 214: 149-160
30. Mohler ER 3rd, Gannon F, Reynolds C et al. Bone formation and inflammation in cardiac valves. Circulation 2001; 103: 1522-1528
31. Becker LE, Koleganova N, Piecha G et al. Effect of paricalcitol and calcitriol on aortic wall remodeling in uninephrectomized ApoE knockout mice. Am J Physiol Renal Physiol 2011; 300: F772-F782
32. Zittermann A, Schleithoff SS, Frisch S et al. Circulating calcitriol concentrations and total mortality. Clin Chem 2009; 55: 1163-1170
33. Zehnder D, Quinkler M, Eardley KS et al. Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation. Kidney Int 2008; 74: 1343-1353
34. Sprague SM, Llach F, AmdahlM et al. Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. Kidney Int 2003; 63: 1483-1490